{"id":82382,"date":"2017-07-10T09:56:46","date_gmt":"2017-07-10T09:56:46","guid":{"rendered":"http:\/\/mostafa.openonline.co.uk\/?guid=165cf2d2ed3471da5942769a5b78eaae"},"modified":"2017-07-10T09:56:46","modified_gmt":"2017-07-10T09:56:46","slug":"news-story-successful-reclassification-of-nasonex-allergy-control-nasal-spray","status":"publish","type":"post","link":"https:\/\/mostafa.openonline.co.uk\/?p=82382","title":{"rendered":"News story: Successful reclassification of Nasonex Allergy Control Nasal Spray"},"content":{"rendered":"<div class=\"govspeak\">\n<p>Nasonex Allergy Control 0.05% Nasal Spray will soon be available to buy over the counter in pharmacies following a public consultation by the Medicines and Healthcare products Regulatory Agency (MHRA). This nasal spray is used to treat the symptoms of allergic rhinitis such as sneezing and a runny, itchy or blocked up nose which may be caused by hay fever.<\/p>\n<p>Nasonex Allergy Control is a nasal spray containing an active ingredient called mometasone furoate. This is the first product containing mometasone furoate to be available without prescription.<br \/>\nMHRA are committed to involving people in their healthcare, and to widen access to medicines for the benefit of public health when it is safe to do.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>MHRA reclassifies Nasonex Allergy Control<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"_links":{"self":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/82382"}],"collection":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=82382"}],"version-history":[{"count":0,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/82382\/revisions"}],"wp:attachment":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=82382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=82382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=82382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}